Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease cystoid macular dystrophy
Symptom C0456909|vision loss
Sentences 23
PubMedID- 21924503 Participants: a total of 24 eyes of 23 subjects with vision loss associated with chronic macular edema from crvo.
PubMedID- 25390168 Rickettsial retinitis: acute unilateral vision loss with cystoid macular edema and stellate maculopathy.
PubMedID- 23831329 Breakdown of the blood-retinal barrier and leakage from the retinal vasculature leads to diabetic macular edema, an important cause of vision loss in patients with diabetes.
PubMedID- 25652875 Diabetes mellitus increases oxidative stress and induces vascular leakage and increased retinal vascular permeability, perhaps causing macular edema which correlates with vision loss in diabetic retinopathy patients .
PubMedID- 21764136 Participants: we included 1256 patients with vision loss owing to macular edema associated with brvo or crvo.
PubMedID- 24294536 vision loss is attributed to cystoid macular edema (one-third of patients), optic atrophy, and rarely choroidal neovascularization.
PubMedID- 25975823 Severe retinopathy and presence of diabetic macular edema (dme) are associated with vision loss in patients with diabetes 1.
PubMedID- 21383939 Laser photocoagulation prevents further vision loss in patients with macular edema caused by diabetes and retinal vein occlusion.13–15 however, the prevention of visual decline is not always uniform, and some patients can be refractory to laser treatment.
PubMedID- 20038863 Purpose: inflammation may play an important role in the pathogenesis of diabetic macular edema, a major cause of vision loss in persons with diabetes.
PubMedID- 21472638 Since novartis gained new indication for lucentis in eu for vision loss due to diabetic macular edema (dme) it is to be expected that vegf inhibition will become first line for patients with dme.
PubMedID- 23392399 Importance: this study demonstrates that increasing quintiles of baseline high-sensitivity c-reactive protein (hscrp) level may be associated with higher risk of incident clinically significant macular edema, the leading cause of vision loss in working-aged individuals in north america.
PubMedID- 21862641 Purpose: patients with diabetic retinopathy may experience severe vision loss due to macular edema and neovascularization secondary to vascular abnormalities.
PubMedID- 21941500 Dexamethasone can lead to a very fast reduction of macular edema in patients with vision loss due to crvo and may facilitate an immediate visual rehabilitation.
PubMedID- 24106640 In nonproliferative disease, the most common cause of vision loss is due to diabetic macular edema (dme).
PubMedID- 20417567 Objective: to evaluate the safety and efficacy of dexamethasone intravitreal implant (dex implant; ozurdex, allergan, inc., irvine, ca) compared with sham in eyes with vision loss due to macular edema (me) associated with branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).
PubMedID- 23528703 Methods: in this prospective cohort study, 13 consecutive patients with vision loss because of clinically significant macular edema associated with diabetes mellitus type 2 underwent grid laser treatment (pascal).
PubMedID- 24205253 Currently the ophthalmologist can choose between different therapeutic options to treat vision loss due to macular edema in rvo.
PubMedID- 21139695 Diabetic macular edema (dme) can lead to considerable vision loss in diabetic patients, especially in those with nonproliferative diabetic retinopathy (npdr).
PubMedID- 20711086 Methods: in a prospective clinical trial, 10 eyes of 10 consecutive patients with vision loss because of diabetic macular edema were compared with 10 eyes of 10 age-matched controls.
PubMedID- 25978399 Retinal vein occlusion is the second most common vascular eye disease and causes vision loss due to macular edema, retinal bleeding and ischemia 1.
PubMedID- 20332345 Increased vascular permeability caused by the breakdown of the blood-retinal barrier (brb) results in diabetic macular edema, a major cause of vision loss in diabetic patients (2,5,6).
PubMedID- 23275801 As the blood content leaked through the rpe barrier causes excessive water influx to the retina, the breakdown of the rpe barrier is likely to play a causative role in the development of some forms of diabetic macular edema, a major cause of vision loss in dr.
PubMedID- 21845032 Until recently, there was no proven, effective therapy for vision loss associated with macular edema secondary to crvo.

Page: 1